Intellia Therapeutics Announces Progress with CRISPR/Cas9 at the American Society of Gene & Cell Therapy Annual … – Nasdaq
Nasdaq |
Intellia Therapeutics Announces Progress with CRISPR/Cas9 at the American Society of Gene & Cell Therapy Annual …
Nasdaq WASHINGTON, May 13, 2017 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on the development of potentially curative therapeutics using CRISPR technology, presented an update on its … CRISPR Therapeutics to Present at Investor Conferences in May CRISPR: The Future of Medicine and Human Evolution » in-Training … China racing ahead to beat cancer with CRISPR gene editing |
